Medical Fluoropolymers Market Predicted to Witness Steady Growth During the Forecast Period

 Medical Fluoropolymers Market Growth & Trends

The global medical fluoropolymers market size is expected to reach USD 962.03 million by 2030, expanding at 9.2% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for advanced medical technology and devices and growing healthcare investments in emerging economies is expected to drive the demand for medical fluoropolymers over the forecast period.

The medical fluoropolymers industry is also expected to witness high adoption of fluoropolymers in implants on account of their chemical inertness and superior fatigue resistance. The demand for medical device packaging is likely to be driven by the rise in the demand for in-house and advanced medical devices.

The global fluoropolymers industry is one of the most heavily regulated in the world. It will be driven by increasing fluoropolymers consumption in construction, automotive, medical devices, and electrical & electronics applications. A large number of players are operating in the market across the globe, with various types of fluoropolymers, such as polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), fluorinated ethylene–propylene (FEP), fluoroelastomers, and others are included as product segments. Other product types include ECTFE, PVF, ETFE, PFA, CTFE-VDF, PCTFE, and THV.

Fluoropolymers have been in high demand as substitutes for alloys and metals in a variety of industries, including industrial machinery, consumer goods, and automobiles in recent years. The industry's criticality rests in technological advancement, as end customers' ever-increasing demands for adaptability and product specification steadily drive the consumer electronics sector.

Other elements that influence industry trends include industrial procedures, feedstock availability, and sociopolitical events. Rapid modernization and availability of trained labor in Asia Pacific's growing economies have fueled the region's manufacturing sector's growth. The global epidemic of highly contagious COVID-19, on the other hand, had a significant impact on manufacturing industries, which, in turn, harmed the growth of the global fluoropolymers industry. Work-from-home policies, order cancellations, and shipping issues are all on the rise in the industry as a result of the pandemic's global spread.

Request a free sample copy or view report summary: Medical Fluoropolymers Market Report

Medical Fluoropolymers Market Report Highlights

• The global medical fluoropolymers industry was valued at USD 475.18 million in 2022 and is estimated to grow at a CAGR of 9.2% from 2023 to 2030
• In terms of revenue, the polytetrafluoroethylene (PTFE) product segment accounted for a significant share of the market in 2022 and is further expected to witness prominent growth over the forecast period. The growth of PTFE can be attributed to its easy blending properties with numerous fillers such as carbon graphite, glass bead, and molybdenum disulfide for enhancing certain end-use applications
• The medical tubing application segment dominated the global market and accounted for more than 37.0% of the market revenue share in 2022. Medical tubing is designed for several applications such as anesthesiology, respiratory equipment, peristaltic pumps, biopsy, and check pump functions. It is also used for diagnosing congenital heart defects to allow clinicians to administer fluids and devices or to enable gas flow
• In 2022, North America accounted for more than 41.0% share of the overall market in terms of revenue. The medical fluoropolymers industry in North America is projected to witness significant growth in the coming years owing to the increased demand for medical fluoropolymers for developing drug delivery devices, medical tubing, catheters, medical bags, etc
• Various strategic initiatives were recorded over the past few years to boost the growth of medical fluoropolymers. For instance, in November 2020, Mueller Corporation launched a new suite of fluoropolymer coatings for medical devices including polytetrafluoroethylene (PTFE), perfluoro alkoxy (PFA), and fluorinated ethylene propylene (FEP) to their existing portfolio

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-fluoropolymers-market

Medical Fluoropolymers Market Segmentation

Grand View Research has segmented the global medical fluoropolymers market based on product, application, and region:

Medical Fluoropolymers Product Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Ethylene Tetrafluoroethylene (ETFE)
• Polytetrafluoroethylene (PTFE)
• Polyvinylidene Fluoride (PVDF)
• Fluoroelastomers
• Others

Medical Fluoropolymers Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Medical Tubing
• Catheters
• Medical Bags
• Drug Delivery Device
• Others

Medical Fluoropolymers Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • GCC Countries

List of Key Players in Medical Fluoropolymers Market

• Daikin Industries, Ltd.
• The Chemours Company
• Solvay SA
• Arkema
• Adtech Polymer Engineering Ltd.
• Dongyue Group Limited
• Saint-Gobain
• L. Gore & Associates, Inc.
• Hitachi, Ltd.
• Holscot Fluoropolymers Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Alzheimer’s Therapeutics Market To Make Great Impact In The Near Future by 2030: Grand View Research Inc.

 Alzheimer’s Therapeutics Market Growth & Trends 

The global Alzheimer’s therapeutics market size is expected to reach USD 15.19 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.99% from 2023 to 2030. Government organizations are engaged in providing funds for Alzheimer's support, care, and research activities, which is projected to fuel the market growth. For instance, in March 2022, the Alzheimer's Society announced to spend around USD 3.5 billion in the coming years on dementia research to improve the care of patients.

Additionally, the Alzheimer's Association with the Alzheimer's Impact Movement (AIM) announced to utilize USD 25 million to implement the BOLD Infrastructure for Alzheimer's Act to create an effective public health substructure for patients. In addition, in September 2021, the South Texas Alzheimer's Disease Center and the Duke/University of North Carolina Alzheimer's Disease Research Center were granted USD 14.8 million over five years by the National Institute of Aging to encourage research on risk factors related to AD. 

Furthermore, an increase in the incidence and cost burden of dementia associated with AD is expected to boost the market growth. According to the Alzheimer's Society, around 900,000 people are living with dementia in the United Kingdom, and it is projected to rise to 1.6 million by 2040 and the incidence of dementia will be 209,600 in the same year. 

The current standard of care is limited to symptom-relieving drugs. Therefore, the approval of disease-modifying anti-amyloid therapeutics is expected to change the treatment landscape. For instance, in June 2021, the U.S. FDA granted accelerated approval to Aduhelm (aducanumab) for the treatment of patients with Alzheimer’s disease. It is a monoclonal antibody that targets cluster forms of amyloid beta present in the brains of patients and stops its formation. Other key anti-amyloid monoclonal antibodies in late-stage clinical trials include Gantenerumab (F. Hoffmann-La Roche Ltd.), Solanezumab (Eli Lilly and Company), and Lecanemab (Eisai Inc./Biogen), among others.  

Request a free sample copy or view the report summary: Alzheimer's Therapeutics Market Report

Alzheimer's Therapeutics Market Report Highlights

• By product, the cholinesterase inhibitors segment held the largest revenue share in 2022 as it is the current standard of care. In March 2022, the U.S. FDA approved the cholinesterase inhibitor Adlarity (donepezil hydrochloride) developed by Corium Inc. for the treatment of patients with AD
• Pipeline drugs are anticipated to witness the fastest growth over the forecast period due to the presence of a strong product pipeline and their expected launch during the forecast period. Biogen’s product lecanemab (BAN2401), an anti-amyloid beta protofibril antibody for treating AD, is currently in phase 3 clinical trials
• The hospital pharmacy end-user segment dominated the market in 2022 owing to the high hospitalization rate. According to Alzheimer’s Association report 2022, approximately 32% of total Medicare beneficiaries with Alzheimer’s have at least one hospital discharge annually

Access Press Release@ https://www.grandviewresearch.com/press-release/global-alzheimers-therapeutics-market

Alzheimer's Therapeutics Market Segmentation

Grand View Research has segmented the global Alzheimer’s therapeutics market by product, end-user, and region:

Alzheimer's Therapeutics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cholinesterase inhibitors
  • Donepezil
  • Galantamine
  • Rivastigmine
• NMDA Receptor Antagonist
• Combination Drug
• Pipeline Drugs

Alzheimer's Therapeutics End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy
• Retail Pharmacy
• E-commerce

Alzheimer's Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Alzheimer's Therapeutics Market

• Eisai Co., Ltd.
• Novartis AG
• AbbVie Inc. (Allergan Plc.)
• Adamas Pharmaceuticals, Inc.
• Lundbeck A/S
• Biogen
• AC Immune
• Hoffmann La Roche Ltd.
• Daiichi Sankyo Company, Limited
• Johnson & Johnson Services, Inc.
• TauRx Pharmaceuticals Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Electrophysiology Devices Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 Electrophysiology Devices Market Growth & Trends

The global electrophysiology devices market size is expected to reach USD 30.09 billion by 2030, expanding at a CAGR of 15.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for electrophysiology procedures is expected to increase owing to the growing geriatric population and frequent cardiac arrhythmias incidents. According to the World Health Organization, the population aged 60 years and above was approximately 1 billion in 2020 and is expected to reach 1.4 billion by 2030. The adoption of diagnostics and ablation techniques among medical professionals has resulted in the high usage of EP products in the past few years and is likely to drive market growth. The development of new products, such as Nanostim-dual-chamber leadless pacemakers, is anticipated to fuel demand for EP products.

Cardiac ablation has gained popularity as the first-line treatment, rendering a 95% success rate for several rhythm disorders, which, in turn, is boosting its demand. Technological developments, such as laser ablation, cryo-ablation, and ultrasound ablation, coupled with optimized mapping techniques are anticipated to augment market growth over the forecast period. For instance, in September 2020, Koninklijke Philips N.V. released new imaging and workflow enhancements for their novel Kodex-EPD cardiac imaging and mapping system. The market was profusely impacted by the COVID-19 pandemic. Disruptions in the supply chain and postponement of elective surgeries declined the sales of EP systems. According to a study published in the Journal of Cardiothoracic Surgery, approximately 50 to 75% of reduction in cardiac surgeries was reported during the pandemic.

The market is now revamped owing to the adoption of digital health and technological advancements in cardiac surgeries. Moreover, virtual clinics were launched for patients suffering from Atrial Fibrillation(AFib) during the pandemic. For instance, in April 2020, the Physician-Patient Alliance for Health and Safety launched Virtual Patient Care for patients suffering from AFib and had treatment with electrophysiology systems. Prominent players are adopting various strategies including new product launches andM&As to strengthen their position. For instance, in June 2020, Boston Scientific Corp. launched Directsense Technology in the U.S. It will monitor the radiofrequency energy delivery effects during the procedures for cardiac ablation. Directsense technology was approved by the U.S. FDA in April 2020 and is available on RHYTHMIA HDx Mapping System.

Request a free sample copy or view report summary: Electrophysiology Devices Market Report

Electrophysiology Devices Market Report Highlights

• Based on type, the ablation catheter segment accounted for the largest share of 45.53% of the market in 2024 due to growing heart failure and arrhythmia incidences, awareness regarding the electrophysiology procedures’ reliability, and advancement in EP technologies
• Based on indication, the atrial fibrillation segment accounted for the largest market share in 2024. It is estimated to register the fastest CAGR of 15.6% during the forecast period. It is the most common type of arrhythmia associated with a high risk of stroke and blood clotting
• Inpatient facilities accounted for the largest end-use segment with over 83.47% share in 2024, attributed to the high number of surgeries performed in hospitals
• North America dominated the market with a revenue share of over 49.45% in 2024, due to the high prevalence of heart failure, growing aging population, and robust healthcare system.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-electrophysiology-devices-market

Electrophysiology Devices Market Segmentation

Grand View Research has segmented the global electrophysiology devices market report based on the device type, indication, end use, and region:

Electrophysiology Devices Device Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Ablation Catheters
  • Radiofrequency (RF) Ablation
  • Cryoablation
  • Pulse Field Ablation
• Diagnostic Catheters
• Laboratory Devices
• Access Devices

Electrophysiology Devices Indication Outlook (Revenue, USD Billion, 2018 - 2030)

• Atrial Fibrillation (AF)
• Non-Atrial Fibrillation

Electrophysiology Devices End Use Outlook (Revenue, USD Billion, 2018 - 2030)

• Inpatient Facilities
• Outpatient Facilities
• Others

Electrophysiology Devices Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Electrophysiology Devices Market

• Boston Scientific Corp.
• Medtronic
• Abbott
• Biosense Webster (Johnson & Johnson Services, Inc.)
• Biotronik
• General Electric Company
• Siemens Healthcare AG
• MicroPort Scientific Corporation
• Koninklijke Philips N.V

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

AI-based Surgical Robots Market is Expected to Amplify USD 25.2 Billion Value by 2030: Grand View Research Inc.

AI-based Surgical Robots Market Growth & Trends

The global AI-based surgical robots market size is expected to reach USD 25.2 billion by 2030, registering a CAGR of 18.9% during the forecast period, according to a new report published by Grand View Research, Inc. Robot-assisted surgery allows physicians to perform several types of complex surgical procedures with more flexibility, fewer risks, and with a faster recovery time. In addition, the incorporation of Artificial intelligence (AI) in robotic surgeries has revolutionized the automated medical devices industry.

The increased success rate and high efficiency of AI-based surgical robots are anticipated to fuel their adoption all around the world. Furthermore, the shift in preference towards automated minimally invasive procedures over conventional methods of surgeries by patients is further boosting the market growth.

Based on type, the instruments and accessories segment dominated the market, with a revenue share of around 54.3% in 2022. This growth can be attributed to the growing adoption of AI-based surgical robots & their accessories and the increasing number of next-generation modern hospitals. In addition, an increase in surgical robot product development activities by manufacturers is also anticipated to drive the segment in the coming years. Moreover, increasing preference for minimally invasive AI-based robotic surgeries is further anticipated to propel segment growth.

Based on application, the others segment dominated the market in terms of revenue share in 2022. The segment includes general surgeries, oncological & laparoscopies interventions, and procedures. The growing prevalence of cancer, heart diseases, and other chronic disorders further increases the adoption of AI-based surgical robots, which, in turn, is likely to drive segment growth. The increase in robot-assisted procedures such as cutting away cancer tissue, coronary artery bypass, kidney removal, and transplants are also expected to fuel segment growth in the coming years.

North America accounted for a high revenue share of around 41.9% in 2022. This growth can be attributed to improved modern healthcare infrastructure, rapid developments in AI-based robotic surgeries, and an increase in healthcare expenditure. In addition, the presence of leading players and continuous innovations in robotic equipment is also expected to boost the market growth in this region.

Moreover, growing awareness and adoption of automated medical devices for surgical procedures is further supporting the high revenue share for this region. Furthermore, the COVID-19 pandemic had a negative impact on the market in 2020, owing to the reduced number of surgical procedures and postponement of elective surgeries. In addition, disruption of the supply chain, continuous lockdowns, and shutdowns also hampered new product developmental activities in 2020. However, the growing preference for automated robotic surgeries and minimally invasive procedures is likely to accelerate market growth during the post-pandemic period.

Request a free sample copy or view report summary: AI-based Surgical Robots Market Report

AI-based Surgical Robots Market Report Highlights

• The global market growth can be attributed to the increased success rate and high efficiency of AI-based surgical robots
• The instruments and accessories segment dominated the market in 2022, which can be attributed to increasing surgical robot product development activities by manufacturers and rising adoption of the devices
• The others segment dominated the market with a revenue share of over 35.5% in 2022, owing to increasing robot-assisted general surgeries and laparoscopies, along with the rising prevalence of conditions such as breast cancer
• North America dominated the market with a high revenue share in 2022, owing to improved modern healthcare infrastructure, rapid developments in AI-based robotic surgeries, and an increase in healthcare expenditure in the region, among others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-artificial-intelligence-based-surgical-robots-market

AI-based Surgical Robots Market Segmentation

Grand View Research has segmented the global AI-based surgical robots market based on type, application, and region:

AI-based Surgical Robots Type Outlook (Revenue, USD Million, 2016 - 2030)

• Services
• Instruments & Accessories

AI-based Surgical Robots Application Outlook (Revenue, USD Million, 2016 - 2030)

• Orthopedics
• Neurology
• Urology
• Gynecology
• Others

AI-based Surgical Robots Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • Australia
  • China
  • Japan
  • South Korea
  • India
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the AI-based Surgical Robots Market

• Accuray Incorporated
• Intuitive Surgical, Inc.
• Medtronic, plc
• Medrobotics Corporation
• Zimmer Biomet
• Stereotaxis, Inc.
• Transenterix, Inc. (Asensus Inc)
• Stryker Corporation
• Activ Surgical, Inc.
• Titan Medical, Inc.
• CMR Surgical, Inc.
• Smith and Nephew

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Payment Orchestration Platform Market Latest Trends, Industry Growth And Forecast To 2030: Grand View Research Inc.

 Payment Orchestration Platform Market Growth & Trends

The global payment orchestration platform market size is expected to reach USD 6.52 billion by 2030, expanding at a CAGR of 24.7% from 2023 to 2030, according to a new study conducted by Grand View Research, Inc. The growing use of smartphones for making payments is anticipated to drive industry growth. Moreover, consumer awareness about multiple payment options and increasing expectations for secure and fast payments contributes significantly to industry development.

According to PYMNTS.com, 27% of small & medium business units across the U.S. have adopted contactless payment methods, and 19% of small & medium businesses have planned to shift towards an e-commerce business model fully or partially. Thus, such shifts require back-end support to manage the sales and the payments to ensure a smooth customer experience throughout the purchase process. Hence, such business shifts are expected to increase the adoption of payment orchestration platforms across various industries and fuel the market’s growth over the forecast period.

Adopting Payment Orchestration Platforms (POPs) offers numerous advantages, such as 24/7 payment services and operational cost-efficiency. Moreover, payment orchestration platform companies are involved in mergers, acquisitions, and partnerships to gain a competitive edge. Companies are also entering into a strategic partnership to develop the payment orchestration platform, thereby driving the growth of the market.

The pandemic has contributed positively to industry growth. Major hospitals and other essential service providers have shifted from traditional payment terminals to online payment methods. Thus, increasing digitalization and the introduction of tech-based payment terminals by key providers are projected to drive the industry's growth.

Request a free sample copy or view report summary: Payment Orchestration Platform Market Report

Payment Orchestration Platform Market Report Highlights

• The B2C segment is expected to witness the fastest growth over the forecast period. The introduction of multiple payment platforms aggressively by major payment orchestration providers and the adoption of these platforms by e-commerce merchants worldwide is expected to drive the growth of the segment
• The advanced analytics & reporting segment is expected to witness the fastest growth over the forecast period. The rising demand for AI-enabled payment platforms and centralized dashboards to increase business productivity is anticipated to drive segment growth
• The e-commercesegment is anticipated to witness the fastest growth over the period. Changing customer expectations and behavior toward online shopping is leading merchants to opt for payment orchestration platforms, which is expected to propel the segment growth
• The Asia Pacific regional market is expected to register rapid growth during the forecast period. The increasing migration of various businesses to this region and the growing e-commerce market is boosting the regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-payment-orchestration-platform-market

Payment Orchestration Platform Market Segmentation

Grand View Research has segmented the global payment orchestration platform market based on type, functionality, end-use, and region:

Payment Orchestration Platform Type Outlook (Revenue, USD Billion, 2017 - 2030)

• B2B
• B2C
• C2C

Payment Orchestration Platform Functionality Outlook (Revenue, USD Billion, 2017 - 2030)

• Cross Border Transactions
• Risk Management
• Advanced Analytics & Reporting

Payment Orchestration Platform End-use Outlook (Revenue, USD Billion, 2017 - 2030)

• BFSI
• E-commerce
• Healthcare
• Travel & Hospitality
• Others

Payment Orchestration Platform Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • UAE
  • Kingdom Of Saudi Arabia (KSA)
  • South Africa

List of Key Players in the Payment Orchestration Platform Market

• CellPoint Digital
• IXOLIT Group
• Payoneer Inc.
• APEXX Fintech Limited
• Rebilly
• Spreedly
• Modo Payments
• Akurateco
• BNT Soft
• Aye4fin GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Image-guided Therapy Systems Market Is Projected To Reach Approximately $6.9 Billion By 2030: Grand View Research Inc.

 Image-guided Therapy Systems Market Growth & Trends

The global image-guided therapy systems market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to reach at a CAGR of 5.2% from 2023 to 2030. Growing geriatric population and increasing cases of chronic diseases are expected to boost the market demand. Other factors propelling the industry growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are driving the industry.

New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Corporation launched ENDO-AID, an AI platform and endoscopy application with computer-aided detection for gastrointestinal applications. The AI platform with an endoscopy system-EVIS X1 enables real-time display. The growing adoption of such advanced systems is expected to drive the industry. The increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on industry growth.

Additionally, many academic institutions are investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute to market expansion. The development of the Image-guided Therapy Program by the Brigham and Women’s Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.

Request a free sample copy or view report summary: Image-guided Therapy Systems Market Report

Image-guided Therapy Systems Market Report Highlights

• North America accounted for the largest revenue share in 2022 owing to the rising geriatric population and high per capita expenditure
• Based on product, the endoscopes segment accounted for the largest revenue share in 2022 owing to technological advancements, high volume of endoscope-guided surgeries, and rising preference for minimally invasive surgeries
• On the basis of application, cardiac surgery emerged as the largest application segment in 2022 owing to factors such as rising prevalence of target diseases, preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac intervention systems
• By end-use, the hospitals segment accounted for the largest revenue share in 2022 as the hospital settings are equipped with technologically advanced devices
• The ambulatory surgery centers segment is projected to expand at the fastest CAGR of 5.9% over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-image-guided-therapy-systems-market

Image-guided Therapy Systems Market Segmentation

Grand View Research has segmented the global image-guided therapy systems market based on product, application, end-use, and region:

Image-guided Therapy Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Computed Tomography (CT) Scanners
• Ultrasound Systems
• Magnetic Resonance Imaging (MRI)
• Endoscopes
• X-ray Fluoroscopy
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)

Image-guided Therapy Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Oncology Surgery
• Gastroenterology
• Others

Image-guided Therapy Systems End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutions

Image-guided Therapy Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Image-guided Therapy Systems Market

• Koninklijke Philips N.V.
• Medtronic
• Siemens Healthineers
• Analogic Corporation
• GE Healthcare
• Varian Medical Systems, Inc.
• Brainlab AG
• Olympus Corporation
• Stryker

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Culture Media Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 

Cell Culture Media Market Growth & Trends

The global cell culture media market size is expected to reach USD 10.70 billion by 2030, registering a CAGR of 12.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. Expansion of biosimilars and biologics, growth in stem cell research, and emerging bio manufacturing technologies for cell-based vaccines are the major factors which are likely to drive the market. For instance, in October 2021, the Australian Government funded the Australian-led stem cell research through USD 25 million in grants.

The expansion of clear, regulatory approval paths for biosimilars in emerging markets is generating great opportunities for biosimilar monoclonal antibodies.  The availability of an approval pathway in the U.S., has led to new opportunities for bio manufacturers to enter major markets around the globe. Biosimilar versions of monoclonal antibodies have the probability to offer cost reductions of 25-30%, and many emerging market countries are vigorously developing pathways for approvals and are swiftly catching up. As this industry is expanding the key biopharmaceutical players are adopting robust culturing technologies to meet the increasing demand; thereby driving the growth of the market.

Moreover, there is growing interest in improving the stem cell culture, because this technology is being used extensively in research for studying the stem cell biology, as well as for therapeutic applications. Furthermore, funding related to this research field has augmented in recent years which has accelerated the growth of the market. In addition to this, key media manufacturers launched new products for stem cell research. For instance, in September 2021, Bio-Techne Corporation launched a novel medium for the maintenance and expansion of induced pluripotent stem cells having applications in both translational and research workflows.

The outbreak of COVID-19 pandemic has improved the demand for well-established cell-based vaccine production technologies. Moreover, it has given rise to a few scientific innovations, particularly in the production and testing of vaccine technology. For instance, the Vero line originated from the African green monkey kidney and has been extensively used for viral vaccine manufacturing. It has also been used for the development of various SARS-CoV variants. ProVeroTM1 Serum-free Medium is one such medium manufactured by Lonza Bioscience which is protein-free, and of non-animal origin designed to support the growth of Vero cells and MDCK.

Moreover, in many European countries, cell-based flu vaccines have been approved. A probable advantage of cell culture technology is that it authorizes faster start-up of the manufacturing of vaccines during the pandemic. Today, the development of superior biological models, the optimization of culture growth medium, and the reduced dependence on animal-derived components endure to drive the rapidly developing vaccine development.

On the other hand, ethical issues concerning the use of animal-derived products hinders the industry growth. For instance, FBS is collected from the blood of fetal calves is one of the major ethical issues of serum containing media. It is projected that 600,000 liters of FBS is achieved from up to 1.8 million bovine fetuses are produced globally every year, presenting momentous scientific and ethical challenges. To overcome this issue, numerous workshops were held in the past on the replacement of fetal bovine serum and possible ways to reduce the use of FBS in media.

Request a free sample copy or view report summary: Cell Culture Media Market Report

Cell Culture Media Market Report Highlights

• By product, the serum-free media (SFM) segment held the highest market share of 36.0% in 2023. The use of serum-free media signifies a significant tool, which allows the researchers to perform specific applications or grow a specific cell type without using serum.
• The biopharmaceutical production segment dominated the market with a revenue share of 42.71% in 2023. Strategic activities by key biopharmaceutical companies, increasing R&D, demand for more reproducible and better-defined media and growing biosimilars marketdrives the segment growth
• By type, the liquid media segment captured the highest revenue share of 62.9% in 2023. This is attributed to increasing number of biopharmaceutical manufacturers, both downstream and upstream, are switching from premixed powders to liquid media and hence, propelling market growth
• By end-user, The pharmaceutical and biotechnology companies segment captured the highest revenue share of 34.25% in 2023, owing to the expansion of the current manufacturing capacities coupled with increasing prevalence of chronic disease which in turn demands for novel therapeutic drugs
• North America dominated the regional market with a revenue share of 37.58% in 2023 due to the growth in the pharmaceutical and biotechnology industry, presence of high R&D investment, and the development of novel culture media products in the region
• Asia Pacific is estimated to grow at the fastest CAGR of 14.92% during the forecast period owing to the increase in awareness associated with the use of the cell culture technique.  

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-culture-media-market

Cell Culture Media Market Segmentation

Grand View Research has segmented the global cell culture media market on the basis of on product, application, type, end-use, and region:

Cell Culture Media Product Outlook (Revenue, USD Million, 2018 - 2030)

• Serum-free Media
  • CHO Media    
  • BHK Medium          
  • Vero Medium          
  • HEK 293 Media         
  • Other Serum-free media
• Classical Media
• Stem Cell Culture Media
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media

Cell Culture Media Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Diagnostics
• Drug Screening And Development
• Tissue Engineering And Regenerative Medicine
  • Cell And Gene Therapy
  • Other Tissue Engineering And Regenerative Medicine Applications
• Other Applications

Cell Culture Media Type Outlook (Revenue, USD Million, 2018 - 2030)

• Liquid Media
• Semi-solid And Solid Media

Cell Culture Media End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical And Biotechnology Companies
• Hospitals And Diagnostic Laboratories
• Research And Academic Institutes
• Other End-users

Cell Culture Media Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Cell Culture Media Market

• Sartorius AG
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• FUJIFILM Corporation
• Lonza
• BD
• STEMCELL Technologies
• Cell Biologics, Inc.
• PromoCell GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Water Enhancer Market to Observe Strong Development by 2030: Grand View Research Inc.

 Water Enhancer Market Growth & Trends

The global water enhancer market size is expected to reach USD 5.84 billion by 2030, registering a CAGR of 9.8% during the forecast period, according to a new report by Grand View Research, Inc. Increasing awareness and adoption of a healthy lifestyle including daily intake of nutritious drinks across the globe act as the major driving force for the industry growth. Moreover, the significant changes in the flavored and healthy water consumption patterns of consumers, especially during the lockdown period, across the globe further contributed to the industry growth. The other factors that drive the market include the growing demand for sports nutrition-based water enhancers. During the COVID-19 pandemic, product sales decreased due to the shutdown of offline retail chains, such as supermarkets, hypermarkets, and convenience stores, across all regions to prevent the spread of the COVID-19 virus. Moreover, the disruption in the supply chain including the import and export further impacted the market during the pandemic.

A significant decline in the import of flavored water-based enhancers in developed economies, such as the U.S., U.K., and Germany, impacted the industry growth during the COVID-19 pandemic. The non-nutritional product segment contributed to a larger revenue share in 2021. The market is mainly driven by the significant demand for water enhancers for flavor and color. Moreover, the availability of various flavors and ingredients in this product category contributes to the larger share of this segment. The nutritional product segment is projected to grow significantly during the forecast period due to the rising demand for healthy beverage products in developed economies. The industry is also analyzed on the basis of the form including liquid and powder. The liquid form segment held the largest market share in 2021.

A rise in the adoption of liquid water enhancer products owing to the convenient packaging is one of the major driving factors that contributed to the market growth. The key manufacturers in the market are mainly offering the liquid form-based water enhancer in flexible and convenient packaging. The powder segment is projected to grow significantly over the forecast period due to the rising focus of emerging companies on launching new products in powder form.

Request a free sample copy or view report summary: Water Enhancer Market Report

Water Enhancer Market Report Highlights

• North America held the largest revenue share in 2021 due to the popularity of nutritious water enhancers as a suitable healthy diet option for all age groups
• Europe accounted for a significant revenue share in 2021 and is expected to grow at a steady CAGR from 2022 to 2030
• Significant growth in the sales of sports and energy water enhancers in Belgium and Italy contributed to the market share
• The rising awareness about healthy water intake in the U.K., Germany, and France will drive the region’s growth during the forecast years
• In addition, the marketing of energy drink mixes products through social media and endorsement by celebrities & athletes further boosts the demand for nutritious water enhancers in this region.
• The online distribution channel segment is expected to register the fastest growth rate during the forecast years
• This growth can be credited to the significant focus of major manufacturers on adopting technologically advanced e-commerce technology to boost their product sales
• Manufacturers are increasingly preferring door-step delivery with nominal tenure by using the online sales platform and mobile application, which also helps customers track the orders.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-water-enhancer-market

Water Enhancer Market Segmentation

Grand View Research has segmented the global water enhancer market based on product, form, distribution channel, and region:

Water Enhancer Product Outlook (Revenue, USD Million, 2017 - 2030)

• Non-Nutritional
• Nutritional

Water Enhancer Form Outlook (Revenue, USD Million, 2017 - 2030)

• Liquid
• Powder

Water Enhancer Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Water Enhancer Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Belgium
  • The Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Singapore
  • Australia
• Central & South America
  • Panama
• Middle East & Africa
  • UAE

List of Key Players of the Water Enhancer Market

• PepsiCo, Inc.
• Nestle S.A.
• The Coca-Cola Company
• The Kraft Heinz Company
• Jel Sert
• SweetLeaf Stevia Sweetener
• Nuun
• Dyla LLC (Stur)
• 4C foods
• Arizona Beverages USA
• Heartland Food Products Group
• Keurig Dr. Pepper
• Mondelez International
• Refresco

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Dual Interface Payment Card Market to Reach Around $23.66 Billion by 2030: Grand View Research Inc.

 Dual Interface Payment Card Market Growth & Trends

The global dual interface payment card market size is expected to reach USD 23.66 billion by 2030, growing at a CAGR of 16.2% from 2022 to 2030, according to a new study conducted by Grand View Research, Inc. The market is anticipated to witness growth due to the increasing usage of payment cards across the globe. For instance, in June 2021, according to the Smart Payment Association (SPA), payment cards consist of 40-60% of total online payments made, either directly or indirectly. At the same time, the strong emphasis of payment service providers on offering enhanced payment solutions to their customers is expected to propel growth.

Increasing strategic collaborations between banks, hybrid smart cards, and dual interface card manufacturing companies to provide better service and upgrade customer experience is expected to drive the market growth during the forecast period. For instance, in December 2020, Kasikornbank extended its partnership with dzcard, a smart card manufacturer. This partnership was aimed at launching a contactless debit card along with a credit line by leveraging dzcard’s dual interface EMV debit card.

The increasing investments by venture capital into the companies offering dual interface cards for payment is anticipated to create new opportunities for the growth of the market during the forecast period. For instance, in April 2022, Financepeer, an Edu-fintech company, raised USD 31 million through a Series B funding round. The funds were utilized to enhance its technology platform and expand its offerings. Later, in June 2022, Financepeer launched a UVA card powered by Visa. This UVA card or a dual-interface card was designed for students to make day-to-day transactions easier. Such initiatives are expected to propel the growth of the industry.

The outbreak of COVID-19 played a vital role in driving the growth of the dual interface payment card market. The COVID-19 pandemic increased the preference for contactless payments among the people while processing payments at restaurants is one of the factors expected to drive the market growth. Moreover, in April 2020, according to a Mastercard survey, almost 8 out of 10 people located globally said that they use contactless payments.

Request a free sample copy or view report summary: Dual Interface Payment Card Market Report

Dual Interface Payment Card Market Report Highlights

• The metal segment is expected to witness the fastest growth during the forecast period. The innovative technological advancements such as fingerprint sensor embedded into cards for biometric payment processing is expected to drive the growth
• The retail segment dominated the market in 2021 owing to the increasing usage of credit cards for online payments. For instance, according to the data released by RBI in march 2022, credit card payments made for e-commerce purchases were 76% more compared to in-store swipes
• The Asia Pacific regional market is expected to witness the fastest growth during the forecast period. The growing awareness of contactless payments across the region is expected to play a decisive role in driving the regional growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dual-interface-payment-card-market

Dual Interface Payment Card Market Segmentation

Grand View Research has segmented the global dual interface payment card market based on type, end-use, and region:

Dual Interface Payment Card Type Outlook (Revenue, USD Million, 2017 - 2030)

• Plastic
• Metal

Dual Interface Payment Card End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Transportation
• Hospitality
• Healthcare
• Retail
• Others

Dual Interface Payment Card Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa (MEA)

List of Key Players in the Dual Interface Payment Card Market

• Thales Group
• IDEMIA
• Valid
• Giesecke+Devrient GmbH
• Eastcompeace Technology Co., Ltd.
• DATANG
• Paragon Group Limited
• CPI Card Group Inc.
• Watchdata Co., Ltd
• Wuhan Tianyu

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fintech As A Service Market Estimated To Flourish By 2030: Grand View Research Inc.

 Fintech As A Service Market Growth & Trends

The global fintech as a service market size is expected to reach USD 949.49 billion by 2030, growing at a CAGR of 17.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing adoption of financial technology-based solutions and platforms globally is anticipated to drive the growth of the market. The increasing adoption of cloud-based software, artificial intelligence, and big data integrated with financial services is expected to drive the growth of the market for Fintech-as-a-Service.

In May 2023, Finastra, a global provider of financial software applications and platforms, joined forces with BKN301 Group, a fintech company committed to removing financial obstacles. This collaboration aims to address financial barriers in rapidly expanding markets. The goal is to introduce inventive solutions that foster economic development, facilitating mutual opportunities between these markets and those in the Western regions.

The investments made in financial technology companies are estimated to generate opportunities for market growth over the forecast period. For instance, in July 2021, an API developer, Railsbank Technology Ltd, raised USD 70 million in a fundraising event headed by Anthos Capital, a U.S.-based investment company. The allocated funds will be utilized to advance the company's Fintech-as-a-service platform and offer customers a range of solutions for product development.

The outbreak of the COVID-19 pandemic is expected to play a crucial role in driving the growth of the Fintech-as-a-Service platform market over the forecast period. The increasing demand for digital financial services increased drastically during the pandemic. Banks and financial institutions were looking at innovative ways to provide their services online during the pandemic which bolstered the growth of the market.

Request a free sample copy or view report summary: Fintech As A Service Market Report

Fintech As A Service Market Report Highlights

• The fund transfer segment is expected to witness the fastest growth over the forecast period. The fund transfer applications and software being introduced such as Meta Pay by some of the major companies worldwide are expected to drive the growth of the segment
• The artificial intelligencesegment is anticipated to witness significant growth over the projected period. Artificial intelligence is experiencing rapid growth due to its ability to automate and optimize financial processes, enhance customer experiences, and provide data-driven insights for better decision-making.
• The KYC verification segment is expected to witness the fastest growth over the forecast period The rising fraudulent activities such as ransomware, and identity theft among others across the globe is one of the major factors that propelled the market growth in 2021.
• The insurance segment is expected to witness the fastest growth over the forecast period. Keeping consumers' changing preferences in mind, insurers are offering flexible-term products and are customizing their offerings according to customer needs. With this changing trend, insurers are adopting Fintech-as-a-Service platforms which is driving the market’s growth
• The Asia Pacific regional market is expected to witness the fastest growth over the forecast period. The growing demand for technology-based payment platforms across the region is expected to play a decisive role in driving the growth of the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-fintech-as-a-service-market

Fintech As A Service Market Segmentation

Grand View Research has segmented the global fintech as a service market based on type, technology, application, end-use, and region:

Fintech As A Service Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Payment
• Fund Transfer
• Loan
• Others

Fintech As A Service Technology Outlook (Revenue, USD Billion, 2017 - 2030)

• API
• Artificial Intelligence
• RPA
• Blockchain
• Others

Fintech As A Service Application Outlook (Revenue, USD Billion, 2017 - 2030)

• KYC Verification
• Fraud Monitoring
• Compliance & Regulatory Support
• Others

Fintech As A Service End-use Outlook (Revenue, USD Billion, 2017 - 2030)

• Banks
• Financial Lending Companies
• Insurance
• Others

Fintech As A Service Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • Kingdom of Saudi Arabia (KSA)
  • UAE
  • South Africa

List of Key Players in the Fintech As A Service Market

• PayPal Holdings, Inc.
• Block, Inc.
• Mastercard Incorporated
• Envestnet, Inc.
• Upstart Holdings, Inc.
• Rapyd Financial Network
• Solid Financial Technologies, Inc.
• Railsbank Technology Ltd.
• Synctera Inc.
• Braintree

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.